Cost remains the major barrier to access of these drugs, or if started, the ability to continue to use them
Florida Blue, UnitedHealthcare, Aetna, Cigna, and Humana may offer coverage depending on your plan
Precision is also paramount in terms of getting optimal treatment for people, and the appeal of different treatments might differ amongst people. GLP-1 Treatments Face Hurdles While GLP-1s offer promising benefits for some patients, significant barriers remain regarding supply, cost, and insurance coveragechallenges that Saunders describes as humongous limitations. Novo Nordisks Ozempic and Wegovy have been on the FDAs drug shortage list since 2022
Are there any sick day rules
Cignarelli, A
FDA-approved prescription medications are available under clinician guidance, including noninjectable options where appropriate